4//SEC Filing
Degnan Chris 4
Accession 0000899243-19-027034
CIK 0001563577other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 7:19 PM ET
Size
5.5 KB
Accession
0000899243-19-027034
Insider Transaction Report
Form 4
Degnan Chris
Chief Financial Officer
Transactions
- Award
Stock Option
2019-11-06+229,513→ 229,513 totalExercise: $12.00Exp: 2029-11-05→ Common Stock (229,513 underlying)
Footnotes (1)
- [F1]The options vests and becomes exercisable with respect to 25% on October 21, 2020 with the remaining shares vesting and becoming exercisable in equal monthly installments over a three year period thereafter.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
Related Parties
1- filerCIK 0001741968
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 7:19 PM ET
- Size
- 5.5 KB